Your Health Plan:
Your Health Plan:
Not SelectedJAKAFI (ruxolitinib) is a brand-name prescription drug for treatment of Polycythemia and Bronchiolitis Obliterans Syndrome. JAKAFI is a kinase inhibitor / kinase inhibitor / janus kinase inhibitor. It is available in the form of oral tablet.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $19200-22500.
Patient Assistance Prorgams and Coupons are found:
No other option is found for JAKAFI